Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

Affiliations

• ¹ Department of Clinical Hematology and Surgery, Division of Hematology, Federico II University of Naples, Naples, Italy. giorgia.battipaglia@unina.it.
• ² EBMT Statistical Unit, Leiden, The Netherlands.
• ³ Dortmunder Centrum für Zelltransplantation (DCZ), Dortmund, Germany.
• ⁴ Sorbonne Université; Centre de Recherche Saint-Antoine INSERM UMRs938; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.
• ⁵ Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland.
• ⁶ RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia.
• ⁷ IRRCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
• ⁸ Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, Bydgoszcz, Poland.
• ⁹ Imperial College, London, UK.
• ¹⁰ Department of Hematology and Transplantology, Lower Silesian Center of Oncology, Wroclaw, Poland.
• ¹¹ Morozov Children's Hospital, Moscow, Russia.
• ¹² Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki University Hospital, Helsinki, Finland.
• ¹³ Charles University Hospital, Pilsen, Czech Republic.
• ¹⁴ EBMT Leiden Study Unit, Leiden, The Netherlands.
• ¹⁵ Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
• ¹⁶ Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.